SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-045502
Filing Date
2017-08-29
Accepted
2017-08-29 10:56:43
Documents
3
Period of Report
2017-09-16
Effectiveness Date
2017-08-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A v474186_def14a.htm DEF 14A 453356
2 GRAPHIC proxycard1.jpg GRAPHIC 257993
3 GRAPHIC proxycard2.jpg GRAPHIC 166627
  Complete submission text file 0001144204-17-045502.txt   1039513
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35182 | Film No.: 171056598
SIC: 2834 Pharmaceutical Preparations